Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial

Author(s):
Teulings, H.E.; Tjin, E.P.M.; Willemsen, K.J.; Kleij, S. van der; Meulen, S. ter; Kemp, E.H.; Krebbers, G.; Noesel, C.J.M. van; Franken, C.L.M.C.; Drijfhout, J.W. (0000-0003-4808-5296); Melief, C.J.M.; Nieuweboer-Krobotova, L.; Nieweg, O.E.; Hage, J.A. van der; Veen, J.P.W. van der; Relyveld, G.N.; Luiten, R.M.
Published
2018
Publication type
Article / Letter to editor
Melanomaimmunotherapyvitiligocutaneous metastases
Date issued
2018-12-31
Language
English
Is part of
OncoImmunology (2018), No. 4
hdl
1887/86729
doi
10.1080/2162402X.2017.1419113
URL
https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1419113